CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 143 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,341 | +4.9% | 151,144 | +8.0% | 0.01% | 0.0% |
Q1 2024 | $2,231 | -10.2% | 139,993 | -5.3% | 0.01% | -16.7% |
Q4 2023 | $2,485 | +43.8% | 147,844 | 0.0% | 0.01% | +50.0% |
Q3 2023 | $1,728 | -12.6% | 147,844 | +0.4% | 0.00% | 0.0% |
Q2 2023 | $1,978 | -18.8% | 147,190 | +0.1% | 0.00% | -33.3% |
Q1 2023 | $2,437 | -6.9% | 147,012 | +4.5% | 0.01% | 0.0% |
Q4 2022 | $2,617 | -99.9% | 140,684 | +0.2% | 0.01% | +20.0% |
Q3 2022 | $1,801,000 | +35920.0% | 140,354 | +12659.5% | 0.01% | – |
Q1 2021 | $5,000 | +25.0% | 1,100 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | +33.3% | 1,100 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | -40.0% | 1,100 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | +25.0% | 1,100 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | – | 1,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |